BDC-3042

Other Medications

Not submitted to EMA

Not available 1 Clinical Trials

Description

BDC-3042 is an experimental medicine being studied by Bolt Biotherapeutics, Inc. It is being investigated as a potential treatment for advanced cancers, including colorectal cancer, although it is not yet approved for this use. Clinical trials have explored BDC-3042 both by itself and in combination with another experimental immunotherapy drug called cemiplimab. These trials, known as Phase 1 studies, were designed to determine the safest dose of BDC-3042 and see if it has any activity against cancer. The trials involved patients with various advanced cancers. The specific trial data for BDC-3042 in colorectal cancer is limited as the trials have been terminated.

Mechanism of Action

BDC-3042 is being studied as a potential cancer treatment. The specific way it works (its mechanism of action) is currently being investigated in clinical trials. It is designed to target cancer cells, potentially by interacting with specific proteins or pathways involved in tumor growth or survival. Further research is needed to fully understand its molecular target and how it affects cancer cells.

Side Effects

As BDC-3042 is an experimental drug and the clinical trials in CRC have been terminated Specific side effect data related to its use in colorectal cancer patients is limited. In general Phase 1 trials focus on safety So common side effects observed in early trials often relate to how the drug is administered or its general effects on the body. More detailed information on side effects would typically be gathered in later-phase trials if the drug continues development. Since the trials have terminated Comprehensive side effect profiles are not available.

Not all side effects are listed. Side effects vary by individual. Always consult your oncologist.

Clinical Trials

NCT06052852 Phase 1

Terminated

Study of BDC-3042 as Single Agent and in Combination With Cemiplimab in Patients With Advanced Malignancies

United States

Quick Info

Category	Other Medications
EMA Status	Not submitted to EMA
Spain Access	Not available
Clinical Trials	1

View Clinical Trials Back to Drug Glossary

Related Medications

Medical Disclaimer

This information is for educational purposes only and should not replace professional medical advice. Always consult your healthcare team before making treatment decisions.